Articles
MDoutlook®: Delivers Precision Intelligence
Jan Heybroek, CEO of MDoutlook, was recently interviewed by Al Simon, a business development strategy leader on Business RadioX. Jan discussed his journey as an entrepreneur. As a successful life sciences professional, Jan recognized unmet needs in medical affairs, marketing and market research. He started MDoutlook and developed a powerful
Continue Reading
Rising stars are the upcoming, bright, talented, technophile medical experts in specialist therapy areas. Their assessment and outlook on emerging treatment approaches inform a successful oncology market research strategy and give life sciences companies an important insight into a treatment’s brand perception among HCPs. These emerging leaders are often digital
Continue Reading
Learn how to navigate the ThoughtLeader landscapes in the new normal. Physicians are facing a major backlog of patient cases after Covid-19 diverted healthcare resources throughout 2020. ThoughtLeaders, or Key Opinion Leaders (KOLs) and, clinicians on the ground are now harder than ever to access and activate, winning share of
Continue Reading
The events of 2020 have necessitated some major changes in ThoughtLeader - otherwise known as Key Opinion Leaders, External (Scientific) Experts, or Key External Experts - engagement strategy. Where resources were typically focussed on the global top 50 or 100 in a given disease area, it's now just as important
Continue Reading
It’s never been more challenging than in today’s dynamic climate for your new products or brands to achieve their full potential. Measuring and communicating success is critical. Implementing the right tracking of your product is imperative for monitoring, interpreting and impacting key performance indicators for your market, your products and
Continue Reading
Rising stars are the upcoming, bright, talented, technophile medical experts in specialist therapy areas. Their outlook on emerging treatment approaches gives an important insight into future treatments. These emerging leaders are often digital influencers as well, making them even more relevant in the current times. Identifying and engaging with the
Continue Reading
MDoutlook, a precision intelligence leader specializing in life science strategies, recently launched Lumineer™, an extension of the company’s proven suite of ThoughtLeader identification solutions. The latest offering in MDoutlook’s thought leadership and precision intelligence services, Lumineer delivers several material differentiators that set it apart from other online Life Science resources.
Continue Reading
The latest release from our annual corporate leadership reveals multiple factors supporting the use of an IO approach having similar impact on treatment decisions. Factors most driving oncologist usage were efficacy and quality of life benefits offered by IO treatments followed by label safety and availability of biomarkers. With little
Continue Reading
With ASCO announcing their inaugural virtual program last week and ahead of other major oncology and hematology conferences (such as EHA) moving online, client appetite for planning their activities have not abated in hiring us to measure impact of their data announcement activity in the current “new norm”. Have you
Continue Reading
Having recently named the 2020 leaders in oncology and ImmunoOncology, our latest release from our annual Corporate Leadership report reveals the key attributes oncologists view as driving successful leadership in IO. “Products” and “R&D/Product Pipeline” are the two most important aspects driving oncologists’ view of Corporate Leadership. The top five
Continue Reading
Links
FDA Drug information:
http://www.fda.gov/Drugs
European Medicines Agency:
http://www.ema.europa.eu/
Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed
Clinical Trials Research:
http://www.clinicaltrials.gov/